Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupixent vs placebo in Japanese pediatric atopic dermatitis
jRCT2031200275Completed
- Sponsor
- Sanofi
- Start
- Jan 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in atopic dermatitis (AD) comparing Dupixent with Placebo (2 arms). Primary endpoint: EASI-75 response at week 16. Started Jan 2021; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2031200275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200275.